Screening Tool Could up Hepatocellular Carcinoma Survival to 90%
A new machine-learning serum fusion-gene model shows promise in increasing hepatocellular carcinoma diagnostic accuracy and monitoring.
Read More
Search Results for: infectious diseases
Point-of-Care HCV Test Receives FDA Marketing Greenlight
The FDA has authorized Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first point-of-care HCV test for certified settings.
Read More
QIAGEN Endorses New AAP Guidelines for Pediatric TB Screening
QIAGEN supports new guidelines recommending the screening of at-risk children of all ages for latent tuberculosis using advanced blood tests.
Read More
Diagnostic Stewardship Approach to C. Diff Reduces Unnecessary Testing
New C. diff testing guidelines lead to a significant reduction in inappropriate testing by 20%, which helped decrease overtreatment.
Read More
FDA to Help Accelerate Diagnostic Device Development for the Underserved
The FDA’s CDRH is developing new analytical methods for breath-based diagnostic devices to enhance disease detection for the underserved.
Read More